Gen Ilac to start share buyback program for up to 125 mln shares
Turkish pharmaceutical company Gen Ilac said it will start a share buyback program for a maximum of 125 million nominal shares using allocated funds of 1.5 billion lira.
Turkish pharmaceutical company Gen Ilac said it will start a share buyback program for a maximum of 125 million nominal shares using allocated funds of 1.5 billion lira.